Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like ROEQ announces Docking Station Precision solution for mobile industrial robots September 13, 2019 Do You Hear What I Hear? Connecting IoT Devices with Sound October 24, 2019 LK Metrology’s 5-Axis Coordinate Measuring Machine April 10, 2019